Dictamen Preliminar de Evaluación de Tecnología Sanitaria N° 005-SDEPFYOTS-DETS-IETSI-2020. Eficacia y seguridad de somatropina administrada con dispositivo electrónico, en comparación con somatropina administrada sin dispositivo electrónico, en el tratamiento de pacientes pediatricos con deficit de hormona de crecimiento [PDF]
, 2020 En este documento se plasma la evaluación de la eficacia y seguridad del uso del producto farmacéutico somatropina administrada con dispositivo electrónico, en comparación con somatropina administrada sin dispositivo electrónico, en el tratamiento de ...
Burela Prado, Paula Alejandra +4 more
core
Ten years' clinical experience with biosimilar human growth hormone: a review of efficacy data
Drug Design, Development and Therapy, 2017 Juan Pedro López-Siguero,1 Roland Pfäffle,2 Philippe Chanson,3 Mieczyslaw Szalecki,4,5 Nadja Höbel,6 Markus Zabransky6 1Servicio de Endocrinología Pediátrica, Hospital Materno-Infantil, Hospital Regional Universitario de M&
López-Siguero JP +5 more
doaj
Sarnased bioloogilised ravimid [PDF]
, 2012 Eesti Arst 2012; 91(9):492 ...
Harrison, Pille, Irs, Alar, Laius, Ott
core +2 more sources
Safety and effectiveness of Omnitrope® (somatropin) in PATRO Children: a multi-center, post-marketing surveillance study comparison of US and international cohort data. [PDF]
Eur J Pediatr, 2022 Backeljauw P +9 more
europepmc +1 more source
AN OVERVIEW OF BIOSIMILARS [PDF]
, 2015 Biosimilars are surmounting pharmaceutical market from last three decades and sale increasing progressively. Advances in the biotechnologylead to development and discovery of new biological products to treat various life-threatening diseases. Biosimilars
Haridas, Kiran +2 more
core +1 more source
Разработка биоаналогов и биоподобного гормона роста [PDF]
, 2021 Rezumat În acest articol s-a efectuat prezentarea informativă despre dezvoltarea biosimilarelor și hormonului de creștere biosimilar în Europa și Republica Moldova, în urma selectării și analizei a 37 de surse bibliografi ce din baza de date PubMed ...
Cazacu, Radu +4 more
core
DEFICIENCIA DE HORMONA DE CRECIMIENTO DE ORIGEN INCIERTO [PDF]
, 2016 La talla baja en pacientes pediátricos es una de los motivos de consulta más frecuentes en Endocrinología cuya correcta valoración y evaluación permite un adecuado manejo diagnóstico y terapéutico.
FERNÁNDEZ VENTUREIRA, VÍCTOR +1 more
core
Switching to Biosimilars in Inflammatory Rheumatic Conditions: Current Knowledge [PDF]
, 2018 Biosimilars are more affordable versions of previously approved biopharmaceuticals that are designed to reduce healthcare expenditure and increase patient access to this therapeutic class. To achieve their economic potential, many European countries have
Filipe C. Araújo +2 more
core
Biosimilar products: evaluation of biosimilarity and comparability [PDF]
, 2013 Al finalizar el periodo de patente de los medicamentos de origen biotecnológico, como las proteínas de origen recombinante y los anticuerpos monoclonales, se ha abierto la posibilidad de fabricar copias de dichos fármacos, denominados medicamentos ...
Calvo Hernáez, Begoña +2 more
core +5 more sources
Maintaining persistence and adherence with subcutaneous growth-hormone therapy in children: comparing jet-delivery and needle-based devices [PDF]
, 2014 PURPOSE: Persistence and adherence with subcutaneous growth hormone (GH; somatropin) therapy in children is widely acknowledged to be suboptimal. This study aimed to investigate how the use of a jet-delivery device, ZomaJet(®), impacts on medication ...
Helen Spoudeas +2 more
core +2 more sources